Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.66 - $3.67 $25,904 - $57,270
15,605 New
15,605 $27,000
Q3 2022

Nov 07, 2022

BUY
$4.27 - $6.39 $16,225 - $24,282
3,800 New
3,800 $18,000
Q1 2022

May 16, 2022

SELL
$5.23 - $7.82 $224,367 - $335,478
-42,900 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$7.29 - $10.97 $312,741 - $470,613
42,900 New
42,900 $321,000
Q3 2021

Nov 09, 2021

SELL
$9.01 - $12.01 $115,931 - $154,532
-12,867 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$10.17 - $12.64 $99,859 - $124,112
9,819 Added 322.15%
12,867 $154,000
Q1 2021

May 14, 2021

BUY
$10.88 - $17.05 $7,050 - $11,048
648 Added 27.0%
3,048 $38,000
Q4 2020

Feb 12, 2021

BUY
$9.23 - $18.18 $22,152 - $43,632
2,400 New
2,400 $37,000
Q2 2020

Aug 13, 2020

SELL
$6.21 - $11.83 $248 - $473
-40 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$5.05 - $8.85 $202 - $354
40 New
40 $0
Q3 2019

Nov 12, 2019

SELL
$9.05 - $12.22 $5,430 - $7,332
-600 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$8.75 - $13.03 $5,250 - $7,818
600 New
600 $6,000
Q4 2018

Feb 13, 2019

SELL
$9.51 - $16.6 $122,964 - $214,638
-12,930 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$13.05 - $19.05 $168,736 - $246,316
12,930 New
12,930 $219,000
Q2 2018

Aug 13, 2018

SELL
$13.9 - $19.8 $6,227 - $8,870
-448 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$16.7 - $26.35 $39,495 - $62,317
-2,365 Reduced 84.07%
448 $8,000
Q4 2017

Feb 12, 2018

SELL
$11.6 - $17.35 $59,310 - $88,710
-5,113 Reduced 64.51%
2,813 $46,000
Q3 2017

Nov 07, 2017

BUY
$8.4 - $15.0 $66,578 - $118,890
7,926
7,926 $118,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.